gvtcx

Executive search for Commercial Medicines Director

NHS England Published 18 Jan 2023 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£33,850
Statuscomplete
Category (CPV) 85100000
Deadline1 Nov 2022
Contract start11 Nov 2022
Contract end11 Feb 2023
Procedureselective
SME suitableYes
OCIDocds-b5fd17-ebda8fc3-943e-4054-ae26-5369b2f628ce

Award

SupplierValueDateStatus
Gatenby Sanderson Limited £33,850 22 Dec 2022 active

description

The scale of the responsibility, and the complexity within which this role operates, will require an individual of significant commercial experience in innovative and generic medicines markets, who will bring the blend of leadership, strategy, science, and commercial skills that can drive the system forwards to benefit patients, healthcare providers and purchasing stakeholders.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
18 Jan 2023 Award (award) · 6bc94f24-b15c-4074-9dce-acf985ff66d5-606583

more from NHS England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.